FDA changes to drug bar code rule could have significant impact on packaging lines
from Healthcare Packaging
Depending on line speeds and label printing requirements, new equipment costs to meet rule could hit $200,000 per line. The discovery in February that counterfeit Avastin, the cancer infusion drug, found its way to physicians and hospitals in the U.S., makes it more likely that the U.S. Food and Drug Administration, either on its own or at the behest of Congress, will allow pharmaceutical manufacturers to change the way they print bar codes on unit-of-use drug packages. The FDA already had announced last October that it was reviewing its 2004 drug bar code rule, which requires drug companies to print a linear bar code containing the product's National Drug Code on the package directly or on a label.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063